Abstract:Aims While variants in KCNQ1 are the commonest cause of the congenital long QT syndrome, we and others find only a small IKs in cardiomyocytes from human induced pluripotent stem cells (iPSC-CMs) or human ventricular myocytes. Methods and Results We studied population control iPSC-CMs and iPSC-CMs from a patient with Jervell and Lange-Nielsen (JLN) syndrome due to compound heterozygous loss of function KCNQ1 variants. We compared the effects of pharmacologic IKs block to those of genetic KCNQ1 ablation, using JLN cells, cells homozygous for the KCNQ1 loss of function allele G643S, or siRNAs reducing KCNQ1 expression. We also studied the effects of two blockers of IKr, the other major cardiac repolarizing current, in the setting of pharmacologic or genetic ablation of KCNQ1: moxifloxacin, associated with a very low risk of drug-induced long QT, and dofetilide, a high-risk drug. In control cells, a small IKs was readily recorded but pharmacologic IKs block produced no change in action potential duration at 90% repolarization (APD90). By contrast, in cells with genetic ablation of KCNQ1 (JLN), baseline APD90 was markedly prolonged compared with control cells (469 ± 20 vs. 310 ± 16 ms). JLN cells displayed increased sensitivity to acute IKr block: the concentration (μM) of moxifloxacin required to prolong APD90 100 msec was 237.4 (median, IQR 100.6-391.6, n = 7) in population cells versus 23.7 (17.3-28.7, n = 11) in JLN cells. In control cells, chronic moxifloxacin exposure (300μM) mildly prolonged APD90 (10%) and increased IKs, while chronic exposure to dofetilide (5 nM) produced greater prolongation (67%) and no increase in IKs. However, in the siRNA-treated cells, moxifloxacin did not increase IKs, and markedly prolonged APD90. Conclusion Our data strongly suggest that KCNQ1 expression modulates baseline cardiac repolarization, and the response to IKr block, through mechanisms beyond simply generating IKs. Translational Perspective Mutations in KCNQ1 – whose expression generates IKs – are the major cause of long QT syndrome. We report here that while pharmacologic IKs block in human cardiomyocytes generates minimal change in repolarization, suppressing KCNQ1 expression markedly increases both baseline repolarization duration and sensitivity to some (but not all) specific IKr blockers. Thus, beyond simply generating IKs, KCNQ1 subserves critical additional role(s) in repolarization control at baseline and in response to IKr block. Our findings imply that assessment of arrhythmic risk in individual patients and by drugs requires a framework that extends beyond a simple one gene-one ion current paradigm.

Retracted: Transcriptional Activation by Stimulating Protein 1 and Post‐transcriptional Repression by Muscle‐specific Micrornas of IKs‐encoding Genes and Potential Implications in Regional Heterogeneity of Their Expressions

Genomic structure, transcriptional control, and tissue distribution of HERG1 and KCNQ1 genes.

Abstract 836: Downregulation of Microrna-1/Microrna-133 and Overexpression of Sp1 Activates Re-expression of Pacemaker Channel Genes HCN2 and HCN4 in Hypertrophic Heart

Differences in the Expression of Neurokinin Receptor in Neural and Bone Marrow Mesenchymal Cells: Implications for Neuronal Expansion from Bone Marrow Cells

Transcriptional Control Of Pacemaker Channel Genes Hcn2 And Hcn4 By Sp1 And Implications In Re-Expression Of These Genes In Hypertrophied Myocytes

Differential Modulations of KCNQ1 by Auxiliary Proteins KCNE1 and KCNE2

Cold-Inducible RNA-Binding Protein Regulates Cardiac Repolarization by Targeting Transient Outward Potassium Channels

Nucleoporin 50 mediates <i>Kcna4</i> transcription to regulate cardiac electrical activity

Overexpression of KCNJ2 Enhances Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications

Down-regulation of miR-1/miR-133 Contributes to Re-expression of Pacemaker Channel Genes HCN2 and HCN4 in Hypertrophic Heart,

An Intragenic Srf-Dependent Regulatory Motif Directs Cardiac-Specific Microrna-1-1/133a-2 Expression

Structural Mechanisms for the Activation of Human Cardiac KCNQ1 Channel by Electro-Mechanical Coupling Enhancers

Transcriptional regulation of the postnatal cardiac conduction system heterogeneity

Nucleoporin 107 Facilitates the Nuclear Export of Scn5a Mrna to Regulate Cardiac Bioelectricity

Abstract 15963: Microrna Biophysically Modulates Cardiac Physiology Via Directly Binding to Ion Channel

Transcriptional Regulation of Heterogeneous Nuclear Ribonucleoprotein K Gene Expression.

Profiling Reduced Expression of Contractile and Mitochondrial mRNAs in the Human Sinoatrial Node vs. Right Atrium and Predicting Their Suppressed Expression by Transcription Factors and/or microRNAs

The electrophysiologic effects of KCNQ1 extend beyond expression of I Ks: evidence from genetic and pharmacologic block

Regulation of Gene Transcription by Voltage-Gated L-Type Calcium Channel, Ca(V)1.3

KCNE2 Modulates the Function of Kv4.3 Channel